Regulatory press release8/8/2025, 1:30 PMThe Swedish Companies Registration Office has granted permission to implement the merger plan between Flerie and Toleranzia
Regulatory press release8/4/2025, 12:20 PMToleranzia brings forward the publication of the Q2-report for 2025
Regulatory press release6/27/2025, 2:40 PMNasdaq Stockholm approves Toleranzia’s application for delisting
Regulatory press release6/25/2025, 4:10 PMToleranzia applies for delisting of the Company’s shares from Nasdaq First North Growth Market, conditional upon completion of the merger with Flerie
Regulatory press release6/5/2025, 10:20 AMAnnouncement from the 2025 Annual General Meeting of Toleranzia AB (publ)
Regulatory press release5/7/2025, 11:50 AMBulletin from extraordinary general meeting in Toleranzia AB
Regulatory press release4/10/2025, 7:05 AMToleranzia AB signs conditional loan agreement of SEK 20 million
Regulatory press release3/25/2025, 9:32 AMStatement by the Board of Directors of Toleranzia in view of the merger offer by Flerie
Regulatory press release3/25/2025, 9:30 AMFlerie and Toleranzia have agreed on a merger plan to take Toleranzia private
Press release3/11/2025, 8:55 AMToleranzia seeks a scientific advice meeting with the Danish Medicines Agency
Regulatory press release2/20/2025, 2:57 PMToleranzia’s clinical trial application (CTA) for TOL2 approved in Germany while declined in Denmark